VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs General Dynamics Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisGeneral Dynamics Corporation
GD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into General Dynamics Corporation's moat claims, evidence, and risks.
View GD analysisComparison highlights
- Moat score gap: General Dynamics Corporation leads (80 / 100 vs 71 / 100 for AstraZeneca PLC).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); General Dynamics Corporation has 4 segments (30.1% in Marine Systems (Nuclear subs + surface shipbuilding)).
- Primary market structure: Oligopoly vs Duopoly. Pricing power: Strong vs Weak.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; General Dynamics Corporation has 11 across 3.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
General Dynamics Corporation
Marine Systems (Nuclear subs + surface shipbuilding)
U.S. Navy nuclear-powered submarine construction and major surface combatant shipbuilding/lifecycle services
United States
Government (primarily U.S. Navy)
Prime contractor / shipbuilder / lifecycle services
30.1%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
General Dynamics Corporation strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
General Dynamics Corporation segments
Full profile >Aerospace (Gulfstream + Jet Aviation)
Oligopoly
Marine Systems (Nuclear subs + surface shipbuilding)
Duopoly
Combat Systems (Land vehicles + munitions)
Oligopoly
Technologies (C5ISR + Federal IT)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.